Antiretroviral therapy among patients with HIV in Almaty, Kazakhstan: the implication for HIV-associated tuberculosis control | Zendy

Alfiya Denebayeva | Zendy; Arpine Abrahamyan | Zendy; Aelita Sargsyan | Zendy; Karine Kentenyants | Zendy; Ainur Zhandybayeva | Zendy; Zhamilya Nugmanova | Zendy; Anarkhan Nurkerimova | Zendy; Karapet Davtyan | Zendy; Marat Tukeyev | Zendy

Open Access

Antiretroviral therapy among patients with HIV in Almaty, Kazakhstan: the implication for HIV-associated tuberculosis control

Author(s) -

Alfiya Denebayeva,

Arpine Abrahamyan,

Aelita Sargsyan,

Karine Kentenyants,

Ainur Zhandybayeva,

Zhamilya Nugmanova,

Anarkhan Nurkerimova,

Karapet Davtyan,

Marat Tukeyev

Publication year - 2020

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.11924

Subject(s) - medicine , guideline , tuberculosis , antiretroviral therapy , odds ratio , human immunodeficiency virus (hiv) , confounding , retrospective cohort study , pediatrics , confidence interval , tb treatment , cohort , disease , immunology , viral load , pathology

Antiretroviral therapy (ART) is an effective preventive strategy against tuberculosis (TB) in people living with HIV (PLWH). In Kazakhstan, according to the revised HIV treatment guideline (2017), ART should be initiated immediately after HIV diagnosis established, regardless of CD4+ count.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research